{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:46:44Z","timestamp":1761709604164},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.humpath.2019.04.010","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T15:55:34Z","timestamp":1556812534000},"page":"71-80","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis"],"prefix":"10.1016","volume":"89","author":[{"given":"Annapurna","family":"Saksena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Cameron","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiehao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sa A.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guilin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto N.","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. Jeffrey","family":"Medeiros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaoying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2019.04.010_bb0005","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ajh.24797","article-title":"Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management","volume":"92","author":"Vose","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0010","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1200\/JCO.2015.63.5904","article-title":"Mantle cell lymphoma","volume":"34","author":"Cheah","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0015","doi-asserted-by":"crossref","first-page":"866","DOI":"10.3109\/10428194.2014.940584","article-title":"Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network","volume":"56","author":"Dreyling","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2019.04.010_bb0020","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1158\/0008-5472.CAN-09-3419","article-title":"Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma","volume":"70","author":"Fernandez","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.humpath.2019.04.010_bb0025","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1172\/JCI61272","article-title":"Molecular pathogenesis of mantle cell lymphoma","volume":"122","author":"Jares","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.humpath.2019.04.010_bb0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00428-015-1840-6","article-title":"Mantle cell lymphoma\u2014a spectrum from indolent to aggressive disease","volume":"468","author":"Sander","year":"2016","journal-title":"Virchows Arch"},{"key":"10.1016\/j.humpath.2019.04.010_bb0035","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3109\/10428194.2013.815353","article-title":"Indolent mantle cell lymphoma","volume":"55","author":"Hsi","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.humpath.2019.04.010_bb0040","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.3324\/haematol.2010.036277","article-title":"Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis","volume":"96","author":"Ondrejka","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.humpath.2019.04.010_bb0045","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.1182\/blood-2002-06-1864","article-title":"A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease","volume":"101","author":"Orchard","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2019.04.010_bb0050","series-title":"WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues","article-title":"Mantle cell lymphoma","author":"Swerdlow","year":"2017"},{"key":"10.1016\/j.humpath.2019.04.010_bb0055","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0167-5699(89)90171-0","article-title":"CD23: a multi-functional receptor\/lymphokine?","volume":"10","author":"Gordon","year":"1989","journal-title":"Immunol Today"},{"key":"10.1016\/j.humpath.2019.04.010_bb0060","first-page":"140","article-title":"Immunophenotyping of non-Hodgkin's lymphoma. Lack of correlation between immunophenotype and cell morphology","volume":"129","author":"Schuurman","year":"1987","journal-title":"Am J Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0065","first-page":"1046","article-title":"Usefulness of an immunohistochemical panel in paraffin-embedded tissues for the differentiation of B-cell non-Hodgkin's lymphomas of small lymphocytes","volume":"11","author":"de Leon","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0070","first-page":"326","article-title":"Distinction between small lymphocytic and mantle cell lymphoma by immunoreactivity for CD23","volume":"7","author":"Dorfman","year":"1994","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0075","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1309\/VWTK-XYT5-D0DK-06HQ","article-title":"Diagnostic usefulness of CD23 and FMC-7 antigen expression patterns in B-cell lymphoma classification","volume":"115","author":"Garcia","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1309\/UQ4N-M5KL-0ANY-YD3G","article-title":"Value of CD23 determination by flow cytometry in differentiating mantle cell lymphoma from chronic lymphocytic leukemia\/small lymphocytic lymphoma","volume":"116","author":"Gong","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0085","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ajcp\/105.4.451","article-title":"The utility of flow cytometric immunophenotypic analysis in the distinction of small lymphocytic lymphoma\/chronic lymphocytic leukemia from mantle cell lymphoma","volume":"105","author":"Kilo","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0090","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0609.1991.tb00557.x","article-title":"Distinct morphophenotypic features of chronic B-cell leukaemias identified with CD1c and CD23 antibodies","volume":"47","author":"Orazi","year":"1991","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/jcp.50.1.16","article-title":"The value of immunohistochemistry on paraffin wax embedded tissue sections in the differentiation of small lymphocytic and mantle cell lymphomas","volume":"50","author":"Singh","year":"1997","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0100","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcp\/110.5.582","article-title":"Flow cytometric and immunohistochemical analysis of small lymphocytic lymphoma, mantle cell lymphoma, and plasmacytoid small lymphocytic lymphoma","volume":"110","author":"Tworek","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0105","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1309\/R94MAFJY5EA4A8C3","article-title":"CD23+ mantle cell lymphoma: a clinical pathologic entity associated with superior outcome compared with CD23\u2212 disease","volume":"130","author":"Kelemen","year":"2008","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0110","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1309\/XV4AG7EMWQU7ER67","article-title":"CD23 expression in mantle cell lymphoma: clinicopathologic features of 18 cases","volume":"120","author":"Schlette","year":"2003","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0115","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/modpathol.2017.135","article-title":"CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course","volume":"31","author":"Hu","year":"2018","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0120","doi-asserted-by":"crossref","first-page":"11441","DOI":"10.18632\/oncotarget.23571","article-title":"CD10-positive mantle cell lymphoma: clinicopathologic and prognostic study of 30 cases","volume":"9","author":"Xu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.humpath.2019.04.010_bb0125","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/modpathol.2015.99","article-title":"Plasma cell and terminal B-cell differentiation in mantle cell lymphoma mainly occur in the SOX11-negative subtype","volume":"28","author":"Ribera-Cortada","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0130","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/modpathol.2015.66","article-title":"Clinical significance of newly emerged isolated del(20q) in patients following cytotoxic therapies","volume":"28","author":"Yin","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0135","series-title":"Recommendations of the International Standing Committee on Human Cytogenetic Nomenclature 1st ed","first-page":"2012","author":"Shaffer LG","year":"2013"},{"key":"10.1016\/j.humpath.2019.04.010_bb0140","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","article-title":"A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma","volume":"111","author":"Hoster","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.humpath.2019.04.010_bb0145","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2013.52.2466","article-title":"Confirmation of the mantle-cell lymphoma international prognostic index in randomized trials of the European Mantle-Cell Lymphoma Network","volume":"32","author":"Hoster","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0150","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2141.1998.00684.x","article-title":"Bone marrow and peripheral blood involvement in mantle cell lymphoma","volume":"101","author":"Cohen","year":"1998","journal-title":"Br J Haematol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0155","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/ajcp\/106.2.196","article-title":"Mantle cell lymphoma. Morphologic findings in bone marrow involvement","volume":"106","author":"Wasman","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2019.04.010_bb0160","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<850::AID-CNCR22>3.0.CO;2-Z","article-title":"Mantle cell lymphoma in leukemic phase: characterization of its broad cytologic spectrum with emphasis on the importance of distinction from other chronic lymphoproliferative disorders","volume":"86","author":"Wong","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.humpath.2019.04.010_bb0165","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/cncr.10401","article-title":"The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease","volume":"94","author":"DiRaimondo","year":"2002","journal-title":"Cancer"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817719300759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T08:06:26Z","timestamp":1563264386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817719300759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"alternative-id":["S0046817719300759"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2019.04.010","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2019.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}